Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
A Large-Scale Proteomics Resource of Circulating Extracellular Vesicles for Biomarker Discovery in Pancreatic CancerBruno Bockorny, Lakshmi Muthuswamy, Ling Huang, et al.
Elife|December 18, 2024
A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancerBruno Bockorny, Lakshmi Muthuswamy, Ling Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2024
A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: The AVATAR TrialFrancesca Sarno, Jair Tenorio, Sofia Perea, et al.
Journal for Immunotherapy of Cancer|December 23, 2025
Botensilimab (Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (anti-PD-1 antibody) in patients with treatment-refractory ovarian cancerRebecca Porter, Bruno Bockorny, Bradley R Corr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021
Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 TrialBruno Bockorny, Teresa Macarulla, Valerya Semenisty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2026
First-in-Human, Phase I Study of Sigvotatug Vedotin, an Integrin Beta-6-Directed Antibody-Drug Conjugate: Results From Dose Expansion in Advanced Non-Small Cell Lung CancerSolange Peters, Sarina A Piha-Paul, Kartik Sehgal, et al.
Molecular Cancer Therapeutics|December 5, 2024
First Results of Migoprotafib, a Potent and Highly Selective Src Homology-2 Domain-Containing Phosphatase 2 Inhibitor in Patients with Advanced Solid TumorsMelissa L Johnson, Beni B Wolf, Judy S Wang, et al.
JCI Insight|September 29, 2020
PDX-derived organoids model in vivo drug response and secrete biomarkersLing Huang, Bruno Bockorny, Indranil Paul, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2021
Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic CancerJoseph E Grossman, Lakshmi Muthuswamy, Ling Huang, et al.
Cancer Immunology Research|September 30, 2024
A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal CancerBrandon M Huffman, Osama E Rahma, Kevin Tyan, et al.
Pageof 5